Search Results for "Ranbaxy Launches Atorvastatin In Us"

16:56 EDT 25th October 2016 | BioPortfolio

Matching Channels


Matching News

Golden Week For Daiichi: Damages Due From Ranbaxy Brothers

In what seems like some consolation for Daiichi Sankyo after its disastrous acquisition of Ranbaxy Laboratories and subsequent divestment of the Indian company, arbitration proceedings in Singapore ag...

Daiichi wins $400M in damages over Ranbaxy drug safety scandal

An arbitration panel found the former controlling stakeholders of Ranbaxy concealed information when they sold the firm to Daiichi Sankyo.

Former Ranbaxy Owners Ordered to Pay $385M for Hiding FDA Probes

The two former owners of India's Ranbaxy Laboratories have been ordered to pay $385 million to Daiichi Sankyo Co., the Japanese pharmaceutical company that bought the drugmaker in 2008.

Concealed compliance info lands ex-Ranbaxy owners $385m costs

The former owners of Indian drugmaker Ranbaxy have been ordered to pay Daiichi Sankyo $385m for concealing quality problems across its manufacturing network before selling the business.

Daiichi Arbitration Case Bares Trail Of Deception At Ranbaxy

Incriminating details in an arbitration order against the former Ranbaxy top brass led by the Singh brothers has put the...    

Ex-Ranbaxy Reps Threaten Sun Pharma Strike

Around 500 Sun Pharma medical representatives, previously employed by Ranbaxy prior to the acquisition by Sun Pharma, are planning a nationwide strike in India to protest unpaid salaries, travel expen...

Japanese drugmaker Daiichi wins damages from former Ranbaxy owners

MUMBAI (Reuters) - The former owners of Indian drugmaker Ranbaxy Laboratories have been ordered by an arbitration court to pay damages worth 25.63 billion rupees ($385 million) to Japan's Daiichi Sank...

BRIEF-Daiichi Sankyo announces outcome of arbitration proceeding with Ranbaxy

* Says Daiichi Sankyo received a final award in the arbitration that it filed with the International Court of Arbitration of the International Chamber of Commerce in November 2012 against the former s...

Matching PubMed Articles

Atorvastatin Use Associated With Acute Pancreatitis: A Case-Control Study in Taiwan.

Few data are present in the literature on the relationship between atorvastatin use and acute pancreatitis. The aim of this study was to explore this issue in Taiwan.Using representative claims data e...

Involvement of PI3K/Akt/GSK-3β and mTOR in the antidepressant-like effect of atorvastatin in mice.

Atorvastatin is a cholesterol-lowering statin that has been shown to exert several pleiotropic effects in the nervous system as a neuroprotective and antidepressant-like agent. Antidepressant-like eff...

Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk.

The use of atorvastatin is rapidly increasing among statins since the introduction of generics. However, only limited data are available on its current use and the effectiveness outside of randomised ...

Amlodipine and atorvastatin improve ventricular hypertrophy and diastolic function via inhibiting TNF-α, IL-1β and NF-κB inflammatory cytokine networks in elderly spontaneously hypertensive rats.

This study aimed to examine the effects of amlodipine and atorvastatin alone or in combination on the regulation of inflammatory cytokines and the underlying mechanisms in elderly spontaneously hypert...

The effect of removing funding restrictions for atorvastatin differed across sociodemographic groups among New Zealanders hospitalised with cardiovascular disease: a national data linkage study.

Publicly-funded atorvastatin required prior approval until September 2010 whereas simvastatin did not. Our aim was to examine if overall statin dispensing and atorvastatin dispensing among patients ho...

Search Whole site using Google

Quick Search
Advertisement Advertisement